Clinical Trial Update: Retrospective Study Evaluating The Current Utilization Of Desvenlafaxine Succinate Sustained-Release (Pristiq) Among Psychiatrists And Primary Care Physicians In The Treatment Of Patients With Major Depressive Disorder

View source ↗

Summary

This completed retrospective study evaluates how Desvenlafaxine Succinate Sustained-Release (Pristiq) is utilized by psychiatrists and primary care physicians t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Pristiq (Desvenlafaxine)

Snippet

Sponsor: Pfizer | Conditions: Major Depressive Disorder | Status: COMPLETED